Relative Acetabular Retroversion and Its Association With Earlier-Onset Symptomatic Osteoarthritis of the Hip

髋臼后倾角及其与髋关节早期症状性骨关节炎的关系

阅读:1

Abstract

BACKGROUND: Hip osteoarthritis is associated with an aging population with the average total hip arthroplasty patient in the U.S. approximately 65 years of age. Although there is an association between femoroacetabular impingement and early arthritis, there is a paucity of data attributed to variation in native acetabular version and early onset osteoarthritis. We investigated that whether patients with relative acetabular retroversion are predisposed to earlier hip osteoarthritis. METHODS: Five hundred sixteen charts of patients undergoing THA by a single surgeon between March 2018 and May 2022 were reviewed (221 male and 295 female subjects; mean age 66.7 years [standard deviation (SD) 9.8]). Patients with advanced dysplasia, who are post-traumatic, septic, have inflammatory arthritis, and osteonecrosis were excluded. Operative hip anteversion was measured using three-dimensional computed tomography. A univariate analysis was used to correlate the age of male and female subjects with anteversion angles of ≤15° and >15°. The effect of age and gender on version angle was studied using a multivariate linear regression model. RESULTS: In patients with anteversion ≤15°, both male (P = .006) and female subjects (P = .015) presented at significantly lesser age (male: 98, avg. age: 63.7, SD: 8.7; female: 62, avg. age: 64.8, SD: 9.8) than those with anteversion >15° (male: 123, avg. age: 67.2, SD: 10.2; female: 233, avg. age: 68.2, SD: 9.8). Male subjects had lower anteversion than female subjects with age held constant (P < .001), and older patients had increased anteversion with gender held constant (P < .001). CONCLUSIONS: This study suggests that patients with a relatively decreased version angle (≤15°) are more likely to present with earlier-onset symptomatic hip osteoarthritis.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。